Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected
Versus retatrutide (the triple agonist) Retatrutide represents the next frontier
Heres what the numbers from that study say
##
That said, muscle soreness and slow recovery can also be tied to: Not enough calories or protein Low iron or B12 Poor sleep High stress load Thyroid patterns Overtraining Underhydration and electrolyte issues So even if someone is curious about BPC-157, you still want to assess the basics
Here's what BPC-157 therapy costs at Moonshot Medical in Park Ridge, IL: $250/mo BPC-157 therapy pharmaceutical-grade compound from a licensed 503A compounding pharmacy Included Medical oversight, personalized dosing protocol, injection training, and monitoring throughout treatment Not Covered Insurance does not cover peptide therapy it's a cash-pay service at all clinics, not just ours Protocol Pricing (save 15-20%) Most patients see meaningful results at 6-12 weeks
